Lobbying

Evolve Foundation International's latest lobbying report covers Q3 2023, at $50K. Its first report covers Q1 2023; the issues it reports most are Medical/Disease Research/Clinical Labs.

Evolve Foundation International

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q1 2023
The first quarter a report named it

Lobbying by quarter

Evolve Foundation International lobbying by quarter
Evolve Foundation International lobbying by quarter
QuarterAmountReports
Q1 2023$35K1
Q2 2023$50K1
Q3 2023$50K1
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Medical research and clinical labs$135K · 3 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES3 reports
  • SENATE3 reports

Firms it paid

Firm
Bluestone Strategies$135K3 quarters

Former officials lobbying for it

Former position
BEHRENDS FOSTERChief of Staff, Representative Dave CampQ3 2023
CHRIS HUCKLEBERRYChief of Staff, Representative Kurt SchraderQ3 2023

Lobbying reports

Filed by
23/10/20for Q3 2023Bluestone Strategies$50K
23/07/20for Q2 2023Bluestone Strategies$50K
23/04/20for Q1 2023Bluestone Strategies$35K
23/03/16for Q1 2023Bluestone StrategiesUnder $5,000